ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; enrollment to start imminently; 12-week study results expected in Q4 2026 ...
Enigma Software, the company behind the SpyHunter security program, is suing tech reviews site BleepingComputer over negative comments it made about its software and what it calls a smear campaign to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results